At Seeker Health, we know, deep in our bones, that NOTHING HAPPENS WITHOUT PATIENTS, and this is why we’ve built an end-to-end DIGITAL PATIENT FINDING PLATFORM.
General Data Protection Regulation, or GDPR, focuses on the protection of personal data – that is any information that relates to an identified or identifiable natural person. At Seeker Health, we care deeply about patient and user privacy. We are GDPR compliant and we hold ourselves to these standards even in countries where this is not yet the legal standard.
Advertising on Facebook, Instagram, Pinterest, Google and other emerging digital platforms is not only an effective tool for finding clinical study participants, but it also makes it possible for advertisers to quickly and inexpensively optimize their advertising campaigns with A/B testing. In A/B testing, two variants of one variable are compared, while all other variables are held constant. With A/B testing, graphics, messaging, timing, duration, frequency, channel, audiences, budget and other variables can be compared. Typically, multiple A/B tests are performed to fine tune a campaign.
Patients were not just "subjects" in a clinical trial, nor were they just numbers on a spreadsheet. Patients were people, real people, wanting to get the most our of their lives. And caregivers, that other word we use frequently, were not just givers of care, but they were the people who would give ANYTHING to see their loved ones get the most out of their lives.
Eighty percent of clinical trials in the United States fail to meet their patient recruitment timelines and 15-20% of activated clinical trial sites never enroll a single patient. Meanwhile, 50% of clinical trial sites don’t reach their enrollment goals. These data make it clear that enrollment is the Achilles’ heel of clinical trials. Before we talk about solutions, we need to understand why we keep getting stuck.
The 2017 holiday season will bring eggnog, presents and lots of social media ads as Facebook, Instagram, and Snapchat promote key retail events like Black Friday and Cyber Monday. Here at Seeker Health, we use social networks for a different purpose: to educate potential participants about clinical trials. But if you’re a company that sponsors or runs clinical trials, you need to know if advertising during the holidays makes sense, and if so, what are the most effective ways. Here are some marketing pros and cons to consider.
Seeker Health worked with a large, global pharmaceutical company enrolling a Phase 3 clinical trial in breast cancer with a genetic modifier to harness the power of social media and technology to accelerate enrollment. We created an engaging social media campaign to accelerate genetic testing, participant identification and clinical trial enrollment. Below, we share our insights on the challenge, our approach and the results of our work.
Seeker Health, a digital health company focused on innovating the way biopharmaceutical companies enroll clinical trials for serious diseases, sat down with Patient Power, an online community for patients with cancer, to understand what might motivate a patient to participate in a clinical trial for cancer. We spoke to Andrew Schorr, the founder of Patient Power (patientpower.info) and a patient himself who has participated in two clinical trials.
Social media usage shows no signs of slowing down. Facebook, Instagram and Twitter boast a collective three billion monthly active users worldwide. Then, there are other social networks, like Pinterest and Snapchat, which have growing user bases. Each platform offers advertising options, which when used in a compliant way, can boost patient enrollment for clinical trials.But which platform is the most effective?
You can help boost patient enrollment by advertising medical research to a large number of people. Currently, around 11 percent of clinical trials in North America include social media communications. Expect this number to skyrocket over the next few years.